Your browser doesn't support javascript.
loading
The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial.
Sargeant, Jack A; King, James A; Yates, Thomas; Redman, Emma L; Bodicoat, Danielle H; Chatterjee, Sudesna; Edwardson, Charlotte L; Gray, Laura J; Poulin, Benoit; Waheed, Ghazala; Waller, Helen L; Webb, David R; Willis, Scott A; Wilding, John P H; Khunti, Kamlesh; Stensel, David J; Davies, Melanie J.
Afiliação
  • Sargeant JA; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • King JA; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.
  • Yates T; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.
  • Redman EL; School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, UK.
  • Bodicoat DH; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Chatterjee S; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.
  • Edwardson CL; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Gray LJ; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.
  • Poulin B; Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Waheed G; Simplified Data, Leicester, UK.
  • Waller HL; Milton Keynes University Hospital, Milton Keynes, UK.
  • Webb DR; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Willis SA; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.
  • Wilding JPH; Department of Health Sciences, University of Leicester, Leicester, UK.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Stensel DJ; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.
  • Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK.
Diabetes Obes Metab ; 24(8): 1509-1521, 2022 08.
Article em En | MEDLINE | ID: mdl-35441435
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Diabetes Obes Metab Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Diabetes Obes Metab Ano de publicação: 2022 Tipo de documento: Article